Lightlake Therapeutics Inc. Launches New Corporate Website, to Host Investor

Lightlake Therapeutics Inc. Launches New Corporate Website, To Host Investor
Filed under: treatments for cocaine

The Company is also announcing the launch of a proof-of-concept research program related to its opioid antagonist patents for the treatment of cocaine, amphetamine and ecstasy abuse and addiction. Members of Lightlake's management team and board of …
Source

 

Delirium Tremens (DTs): Symptoms, Causes, Risks and Treatments
Filed under: treatments for cocaine

Withdrawal from barbiturates, cocaine, even caffeine can also cause delirium tremens. The most severe form of delirium tremens occurs after a period of heavy drinking, especially if you do not eat enough food. It also affects people who have had an …
Source

 

Developing Drugs to End Cocaine Addiction


Emory’s David Weinshenker, PhD, describes research into drugs that can be used to assist in ending cocaine addiction, in particular preventing relapses. Background Disulfiram has been used as a means to fight alcohol addiction; after taking the drug, people who drink had a bad reaction, worse than any hangover, and thus develop an aversion to alcohol. Scientists are now working on a similar drug for the treatment of cocaine addiction. Originally tests were done using disulfiram but now research is moving towards drugs like nepicastat that target only dopamine beta-hydroxylase (DBH). Discussing this research is David Weinshenker, PhD, a Associate Professor of Human Genetics at the Emory University School of Medicine. Related Links Experimental Treatments for Cocaine Addiction May Prevent Relapse shared.web.emory.edu Profile: David Weinshenker genetics.emory.edu Emory Department of Human Genetics genetics.emory.edu

 

More Treatments For Cocaine Information…